Efficacy, Tolerability and Acceptability of Biktarvy by TPLWH
Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
This is a clinical trial for TPLWH (Trans People Living with HIV) who are stable on cART with
an undetectable viral load or a detectable viral load but no resistance to NRTIs and InSTI.
Following written consent and screening procedures, study subjects will undergo a switch (or
will restart) of their combination antiretroviral therapy (cART) to Biktarvy. The goal of
this research project is to recruit an understudied population into a controlled clinical
trial aimed at optimizing TPLWH cART. This will be demonstrated by measuring viral load
outcomes at regular intervals, with a focus on viral load results 48 weeks after Biktarvy
initiation (primary outcome).